Two researchers from the Andalusian public health, in the direction of national programs of Predictive Medicine and Data Science
Mª José Sánchez-Pérez, scientific director of the Biosanitary Research Institute of Granada, and Joaquín Dopazo, director of the Bioinformatics Area of the Progreso y Salud Foundation, join the steering committee of these IMPACT programs, key in the National Strategy for Personalized Medicine .
Two Andalusian public health researchers, Mª José Sánchez-Pérez and Joaquín Dopazo, have joined the steering committees of the IMPACT Predictive Medicine and Data Science programs, respectively, promoted by the Carlos III Health Institute. These programs, together with Genomic Medicine, are the three essential parts of the National Strategy for Personalized Medicine of the National Health System. Their incorporation highlights the scientific and academic level of these two researchers, as well as the potential of R&I in health in Andalusia and its value in the context of the State.
The programs included in IMPaCT are aligned with three areas that will be developed in the future national strategy: Predictive Medicine, Data Science and Genomic Medicine. Professionals from different Spanish scientific and health institutions participate in each of the three programs, led by a person who will act as coordinator and person in charge of the action plan.
Thus, the Predictive Medicine program, in whose steering committee Dr. Mª José Sánchez-Pérez participates, is oriented to the design and implementation of a population cohort of 200.000 people with clinical, epidemiological and biological data that allows to represent the totality of the Spanish population. The objective is to generate a cohort of individual and population, clinical, epidemiological and lifestyle data, which, through its monitoring and updating over time, is the basis for better decision-making in health; It will allow the construction of predictive models of disease risk, identify inequalities in health, monitor key indicators and evaluate the impact of health policies.
The Data Science Program, in which Dr. Joaquín Dopazo participates, seeks to support the development of a common, interoperable and integrated system for the collection and analysis of clinical and molecular data, providing the knowledge and resources available in the Spanish Science and Technology System. This development will allow answering research questions based on the different clinical and molecular information systems available. Fundamentally, this Program seeks to provide researchers with a population perspective based on individual data.
For its part, the Genomic Medicine program will develop infrastructures and coordination protocols to carry out genomic analyzes and other "omics" data throughout the national territory, taking as support state-of-the-art sequencing technologies and already existing experiences for their application to the diagnosis of human diseases.